Ritzen Anouk SRL
Ritzen Anouk reported total assets of €1.25m at the end of the 2025 financial year (annual accounts filed with the NBB on 19 May 2026).
The score of Ritzen Anouk shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -3 % Total assets -1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ritzen Anouk's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 107,506 € | ||||
| Equity | 507,589 € | ||||
| Cash | 11,622 € | ||||
| EBITDA | 180,109 € | ||||
| Total assets | €1.25m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 May 2026
- Year ended 31 Dec 2024filed on 09 Jun 2025
- Year ended 31 Dec 2023filed on 10 Jun 2024
- Year ended 31 Dec 2022filed on 30 May 2023
- Year ended 31 Dec 2021filed on 31 May 2022
Ritzen Anouk's financial analysis
- Solvency40.8%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ritzen Anouk
Ritzen Anouk's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0818.911.117
- VAT number
- BE0818911117
- Peppol
- Registered · 0208:0818911117 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Sep 2009
- Registered office
- 3140 Keerbergen
- Latest accounts
- 2025 · filed on 19 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Ritzen Anouk (SRL) has been based in Keerbergen since 2009, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 107,506 € and equity of 507,589 €; its revenue is not published. Its solvency stands at 40.8%, below the median of its sector (44.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Ritzen Anouk
Companies in the same business, of comparable size and area, outside its group.
- Decopharma Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €1.36m
- De Spiegeleere - Discart Retail sale of pharmaceutical products Braine-l'Alleud · balance sheet €1.36m
- Pharmacie de Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Alba2RO Retail sale of pharmaceutical products Gembloux · balance sheet €1.25m
- Apotheek Vanlaer Retail sale of pharmaceutical products Hasselt · balance sheet €1.25m
- Sanifar Retail sale of pharmaceutical products Ghent · balance sheet €1.24m
- EASI Retail sale of pharmaceutical products Ciney · balance sheet €1.24m
- HM Pharma Retail sale of pharmaceutical products Pittem · balance sheet €1.25m
Frequently asked questions about Ritzen Anouk
What is the revenue of Ritzen Anouk?
Ritzen Anouk files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ritzen Anouk?
In Belgium, the VAT number is the company number prefixed with BE: BE0818911117 for Ritzen Anouk, if the company is VAT-registered. Its company number (CBE) is 0818.911.117.
Where is the registered office of Ritzen Anouk?
According to the CBE register, the registered office of Ritzen Anouk is in 3140 Keerbergen.
What is the equity of Ritzen Anouk?
At the close of the 2025 financial year, the equity of Ritzen Anouk amounts to 507,589 €, a solvency of 40.8% of total assets.
Who manages Ritzen Anouk?
The register lists 2 active mandates at Ritzen Anouk. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ritzen Anouk
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →